EXPESURE Trademark

Trademark Overview

On Thursday, January 15, 2009, a trademark application was filed for EXPESURE with the United States Patent and Trademark Office. The USPTO has given the EXPESURE trademark a serial number of 77650562. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 1, 2019. This trademark is owned by Glaxo Group Limited. The EXPESURE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
expesure

General Information

Serial Number77650562
Word MarkEXPESURE
Filing DateThursday, January 15, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 1, 2019
Registration Number4307118
Registration DateTuesday, March 26, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 27, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 1, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Friday, November 1, 2019CANCELLED SEC. 8 (6-YR)
Monday, March 26, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 26, 2013REGISTERED-PRINCIPAL REGISTER
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 7, 20131(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, January 4, 2013NOTICE OF ALLOWANCE CANCELLED
Friday, January 4, 2013TEAS DELETE 1(B) BASIS RECEIVED
Friday, July 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 19, 2012EXTENSION 5 GRANTED
Tuesday, July 17, 2012EXTENSION 5 FILED
Tuesday, July 17, 2012TEAS EXTENSION RECEIVED
Thursday, January 12, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 11, 2012EXTENSION 4 GRANTED
Monday, January 9, 2012EXTENSION 4 FILED
Monday, January 9, 2012TEAS EXTENSION RECEIVED
Tuesday, June 28, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 27, 2011EXTENSION 3 GRANTED
Friday, June 24, 2011EXTENSION 3 FILED
Friday, June 24, 2011TEAS EXTENSION RECEIVED
Tuesday, December 7, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 6, 2010EXTENSION 2 GRANTED
Wednesday, December 1, 2010EXTENSION 2 FILED
Wednesday, December 1, 2010TEAS EXTENSION RECEIVED
Saturday, August 7, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 6, 2010EXTENSION 1 GRANTED
Tuesday, July 6, 2010EXTENSION 1 FILED
Friday, August 6, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 6, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 19, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Saturday, October 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 27, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2009PUBLISHED FOR OPPOSITION
Thursday, September 24, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 22, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, September 13, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, September 13, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, September 13, 2009ASSIGNED TO LIE
Thursday, September 10, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 6, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 6, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, March 28, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 28, 2009NON-FINAL ACTION E-MAILED
Saturday, March 28, 2009NON-FINAL ACTION WRITTEN
Friday, March 27, 2009ASSIGNED TO EXAMINER
Wednesday, January 21, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

expesure pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic